This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2005 Aug 20;23(24):5420-3.

doi: 10.1200/JCO.2005.04.905.

Ecteinascidin-743 (ET-743): early test or effective treatment in soft tissue sarcomas?

PMID: 16109999
DOI: 10.1200/JCO.2005.04.905

Editorial

Ecteinascidin-743 (ET-743): early test or effective treatment in soft tissue sarcomas?

Jaap Verweij. J Clin Oncol. 2005.

. 2005 Aug 20;23(24):5420-3.

doi: 10.1200/JCO.2005.04.905.

Author

PMID: 16109999
DOI: 10.1200/JCO.2005.04.905

No abstract available

PubMed Disclaimer

Comment on

Ecteinascidin-743 (ET-743) for chemotherapy-naive patients with advanced soft tissue sarcomas: multicenter phase II and pharmacokinetic study.
Garcia-Carbonero R, Supko JG, Maki RG, Manola J, Ryan DP, Harmon D, Puchalski TA, Goss G, Seiden MV, Waxman A, Quigley MT, Lopez T, Sancho MA, Jimeno J, Guzman C, Demetri GD. Garcia-Carbonero R, et al. J Clin Oncol. 2005 Aug 20;23(24):5484-92. doi: 10.1200/JCO.2005.05.028. J Clin Oncol. 2005. PMID: 16110008 Clinical Trial.

Similar articles

[Trabectedin (ET-743/Yondelis) for treating soft tissue sarcomas and ovarian cancer].
Gennigens C, Jerusalem G. Gennigens C, et al. Rev Med Liege. 2011 Jul-Aug;66(7-8):452-5. Rev Med Liege. 2011. PMID: 21942081 French.
Sea squirt assaults sarcomas.
Burton A. Burton A. Lancet Oncol. 2002 Nov;3(11):648. doi: 10.1016/s1470-2045(02)00914-2. Lancet Oncol. 2002. PMID: 12424055 No abstract available.
Ecteinascidin-743.
Held-Warmkessel J. Held-Warmkessel J. Clin J Oncol Nurs. 2003 May-Jun;7(3):313-9. doi: 10.1188/03.CJON.313-319. Clin J Oncol Nurs. 2003. PMID: 12793338 Review.
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial.
Le Cesne A, Blay JY, Judson I, Van Oosterom A, Verweij J, Radford J, Lorigan P, Rodenhuis S, Ray-Coquard I, Bonvalot S, Collin F, Jimeno J, Di Paola E, Van Glabbeke M, Nielsen OS. Le Cesne A, et al. J Clin Oncol. 2005 Jan 20;23(3):576-84. doi: 10.1200/JCO.2005.01.180. J Clin Oncol. 2005. PMID: 15659504 Clinical Trial.
[Ecteinascidin 743].
Lansiaux A, Bailly C. Lansiaux A, et al. Bull Cancer. 1999 Feb;86(2):139-41. Bull Cancer. 1999. PMID: 10094523 Review. French. No abstract available.

See all similar articles

Cited by

The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin.
Kasper B, Schmitt T, Wuchter P, Dimitrakopoulou-Strauss A, Ho AD, Egerer G. Kasper B, et al. Mar Drugs. 2009 Jul 17;7(3):331-40. doi: 10.3390/md7030331. Mar Drugs. 2009. PMID: 19841717 Free PMC article.
Population pharmacokinetic meta-analysis of trabectedin (ET-743, Yondelis) in cancer patients.
Perez-Ruixo JJ, Zannikos P, Hirankarn S, Stuyckens K, Ludwig EA, Soto-Matos A, Lopez-Lazaro L, Owen JS. Perez-Ruixo JJ, et al. Clin Pharmacokinet. 2007;46(10):867-84. doi: 10.2165/00003088-200746100-00005. Clin Pharmacokinet. 2007. PMID: 17854236

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information